Open an account

National Research

NRC · NASDAQ

$20.69+$0.22 (+1.07%)TodayMarket closed ·
Prev close $20.47

About NRC

National Research Corp. engages in the provision of analytics and insights that facilitate patient, employee, and customer retention. The company is headquartered in Lincoln, Nebraska and currently employs 357 full-time employees. Its digital solutions consist of four solution categories: Patient Experience, Consumer Experience, Employee Experience, and Market Experience, which can be implemented both collectively as an enterprise solution or individually to meet specific needs within the organization. Its Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators, and enhanced segmentation tools. Its Reputation solutions allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs better consumer decision-making.

Employees
357
Headquarters
Lincoln, Nebraska
Listed
Oct 1, 1997
Sector
Health Care
Industry
Health Care Providers & Services
Website
nrchealth.com

NRC key statistics

Market cap
457.65M
Price-earnings ratio
85.29
Dividend yield
2.78%
Average volume
103.42K
Volume
74.70K
Open price
$20.47
High today
$21.07
Low today
$20.43
52 Week high
$23.68
52 Week low
$11.32

National Research (NRC) at a glance

National Research (NRC) last traded at $20.69, with a market cap of 457.65M, a price-to-earnings ratio of 85.29 and a dividend yield of 2.78%.

Today the stock has traded between $20.43 and $21.07. The current price is 1.3% above the day's low and 1.8% below its high.

Volume so far is 74.70K shares, below the average of 103.42K shares a day.

Over the past year National Research has ranged from $11.32 to $23.68, and now sits 76% of the way up that range.

National Research met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $0.31 per share against an estimate of $0.1414.

The average analyst price target is $26.52, 28.2% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 1 analyst rating say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 2 analystsAvg $26.52
Low
$26.26
Now
$20.69
High
$27.30

NRC earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 19.8% on average.

  1. Q1 FY18: reported $0.17 per share against an estimate of $0.2929
  2. Q2 FY18: reported $0.28 per share against an estimate of $0.2626
  3. Q1 FY19: reported $0.32 per share against an estimate of $0.3131
  4. Q2 FY19: reported $0.29 per share against an estimate of $0.2626
  5. Q3 FY25: reported $0.23 per share against an estimate of $0.00
  6. Q4 FY25: reported $0.16 per share against an estimate of $0.00
  7. Q1 FY26: reported $0.21 per share against an estimate of $0.00
  8. Q2 FY26: reported $0.31 per share against an estimate of $0.1414

NRC news

  • Press releaseBusiness Wire

    New NRC Health Research Reveals What Sets High-Performing Health Systems Apart: Turning Patient Feedback Into Action

  • Press releaseBusiness Wire

    The Governance Institute Blue Ribbon Committee Reframes Hospital and Health System Board Assessment with Four Considerations for Stronger Governance

  • Press releaseBusiness Wire

    KLAS First Look: NRC Health Rounding Earns 91.6 Overall Performance Score

  • Press releasePRNewswire

    Mercy Earns National Honor for Excellence in Patient Experience

  • Press releaseBusiness Wire

    NRC Health Announces 2026 Award Winners Recognizing Excellence Across Healthcare

  • 12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • Press releaseBusiness Wire

    New NRC Health Research Reveals What Drives Patient Loyalty Beyond Access

  • Press releaseBusiness Wire

    NRC Health Announces Second Quarter 2026 Results

Similar companies

Companies in the same industry as National Research

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.